dr. gomella discusses role of brca1/2 in prostate cancer
Published 5 years ago • 259 plays • Length 1:18Download video MP4
Download video MP3
Similar videos
-
1:11
dr. gomella discusses precision medicine in prostate cancer
-
8:37
brca1 and brca2 mutations & cancer (types of cancer, and who’s most at risk)
-
1:12
dr. gomella on the role of psa in early detection of prostate cancer
-
1:09
dr. gomella on challenges facing genetic testing in prostate cancer
-
1:09
dr. gomella on the challenges of genetic testing in prostate cancer
-
15:35
lu-psma radioligand therapy
-
14:51
brca genetic testing: what to know & why its important
-
13:30
16 years: surviving metastatic #prostatecancer | joel nowak, ceo of @cancerabcs4642 | #pcri
-
12:07
parp inhibitors in brca1/2-mutated patients in prostate cancer
-
0:54
dr. gomella on potential impact of targeted therapy approvals on genetic testing in prostate cancer
-
1:24
dr. gomella on the prevalence of genetic testing in prostate cancer
-
1:22
dr. gomella on the evolution of genetic testing in prostate cancer
-
1:37
dr. gomella on the state of genetic testing and screening in prostate cancer
-
1:27
dr. gomella on screening recommendations in prostate cancer
-
0:57
dr. gomella on immunotherapy developments in prostate cancer
-
0:44
dr. gomella on enzalutamide in prostate cancer
-
28:57
cancer risks, screening and prevention for people with brca1 or brca2 mutations by judy garber, md
-
1:42
ask dr. domchek: the differences between brca1 and brca2
-
1:50
brca2 gene implicated in rare but lethal prostate cancer
-
1:32
dr. gomella on screening in prostate cancer
-
1:11
dr. gomella on the evolution of ar inhibitors in prostate cancer
-
1:07
understanding prostate cancer mutations is critical